Klcm Advisors, Inc. Abb Vie Inc. Transaction History

Klcm Advisors, Inc.

$758 Million
Q1 2024

A detailed history of Klcm Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Klcm Advisors, Inc. holds 24,489 shares of ABBV stock, worth $4.2 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

24,489

Previous 25,007 2.07%

Holding current value

$4.2 Million

Previous $3.88 Million 15.07%

% of portfolio

0.59%

Previous 0.61%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	SELL	$159.82 - $182.1 $82,786 - $94,327	-518 Reduced 2.07%	24,489 $4.46 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $34,124 - $38,432	-248 Reduced 0.98%	25,007 $3.88 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $164,850 - $190,838	1,234 Added 5.14%	25,255 $3.76 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $1.77 Million - $2.21 Million	13,384 Added 125.82%	24,021 $3.24 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $64,206 - $73,943	444 Added 4.36%	10,637 $1.7 Million

Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $9,543 - $11,445	-69 Reduced 0.67%	10,193 $1.65 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $148,973 - $170,862	1,110 Added 12.13%	10,262 $1.38 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $249,505 - $317,202	1,813 Added 24.7%	9,152 $1.4 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $109,578 - $138,648	-1,020 Reduced 12.2%	7,339 $994,000
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $40,325 - $45,775	-379 Reduced 4.34%	8,359 $902,000
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $100,685 - $112,169	-957 Reduced 9.87%	8,738 $984,000
Q1 2021 Apr 21, 2021	BUY	$102.3 - $112.62 $20,460 - $22,524	200 Added 2.11%	9,695 $1.05 Million
Q4 2020 Jan 26, 2021	SELL	$80.49 - $108.67 $2,414 - $3,260	-30 Reduced 0.31%	9,495 $1.02 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $3,006 - $3,529	35 Added 0.37%	9,525 $834,000
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $2,257 - $3,422	35 Added 0.37%	9,490 $723,000
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $61,310 - $76,712	-850 Reduced 8.25%	9,455 $837,000
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $15,745 - $18,930	250 Added 2.49%	10,305 $780,000
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $2,956 - $3,779	45 Added 0.45%	10,055 $731,000
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $78,374 - $92,242	1,016 Added 11.3%	10,010 $807,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $35,032 - $43,204	-450 Reduced 4.76%	8,994 $829,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $266 - $296	-3 Reduced 0.03%	9,444 $893,000
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $69,848 - $82,646	778 Added 8.97%	9,447 $875,000
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $237,477 - $318,005	-2,581 Reduced 22.94%	8,669 $821,000
Q4 2017 Feb 15, 2018	SELL	$89.56 - $98.21 $134,340 - $147,315	-1,500 Reduced 11.76%	11,250 $1.09 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $55,879 - $71,376	-800 Reduced 5.9%	12,750 $1.13 Million
Q2 2017 Aug 15, 2017	BUY	N/A	13,550	13,550 $983,000

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klcm Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Klcm Advisors, Inc. with notifications on news.

Account

Klcm Advisors, Inc. Abb Vie Inc. Transaction History